← Back to Search

ProVent-14 Score for Patients on Mechanical Ventilation

N/A
Recruiting
Research Sponsored by Rush University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one-year after participant enrollment
Awards & highlights

Summary

This trial aims to assess whether a specific scoring system, called the ProVent-14 score, can help ICU clinicians make more accurate predictions about the chances of a patient on mechanical ventilation surviving for a year

Who is the study for?
This trial is for ICU day-shift clinicians (attending physicians, fellow physicians, advanced practice providers, or nurses) who are caring for patients needing mechanical ventilation 14-16 days after intubation and not transitioning to comfort-focused care.
What is being tested?
The study tests if ICU clinicians make more accurate one-year mortality predictions when they know a patient's ProVent-14 score—a simple tool that estimates death risk based on conditions at day 14 of mechanical ventilation.
What are the potential side effects?
There are no direct side effects from using the ProVent-14 score as it is a prognostic tool rather than a medical treatment. The focus is on its impact on clinician decision-making.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one-year after participant enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and one-year after participant enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Accuracy of one-year mortality rate predictions
Secondary outcome measures
Accuracy of timing of patient death
Comfort communicating prognosis to patient/surrogate
Confidence in prediction
+1 more
Other outcome measures
Accuracy of factors influencing prediction

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ProVent-14 Guided Prognostic ApproachExperimental Treatment1 Intervention
Participants will be asked to form a prognosis after being provided the patient's ProVent-14 score and its meaning
Group II: Usual Prognostic ApproachActive Control1 Intervention
Participants will make form a prognosis using their usual approach

Find a Location

Who is running the clinical trial?

Rush University Medical CenterLead Sponsor
431 Previous Clinical Trials
158,163 Total Patients Enrolled
~159 spots leftby Jun 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top